Hikma participates in ‘World Economic Forum on the Middle East and North Africa’ at Dead Sea, Jordan

Amman, Jordan, 8 April 2019 - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody’s / BB+ S&P, both stable), the multinational generic pharmaceutical company, participated in the World Economic Forum Middle East and North Africa (MENA), which took place on 6 and 7 April at the King Hussein bin Talal Convention Centre, Dead Sea, Jordan. The event focused on how the MENA region will achieve socio-economic progress in the age of the Fourth Industrial Revolution driven by new technology and data.

Press Release Responsibility 8 April 2019

Attended by Their Majesties King Abdullah II and Queen Rania Al Abdullah, the event convened over 1,000 key government, business and civil society leaders from 50 countries to prompt collaboration and action-oriented dialogue on the most pressing challenges facing the MENA.  Attendees were challenged to consider how the region can make progress on the regional and national agendas for inclusive economic growth, social advancement and sustainable development across diverse sectors.     

Mazen Darwazah, Executive Chairman and President of MENA, spoke on a panel entitled ‘New Platforms for Healthcare’ - discussing the shift of the healthcare industry towards digitisation. The panel explored topics including investment into health tech, the changing doctor-patient relationship, the implications of real-world data, as well as access and affordability, among others.

Commenting on Hikma’s involvement, Darwazah stated, “The MENA region is one of the world’s most rapidly transforming regions, demographically, socially, politically, economically and environmentally, with some estimates that our population will exceed that of China by the end of the century. It is essential we work together at forums like this to ensure that we are able to help how industry organisations and communities across the MENA interact and impact one another to meet these challenges and opportunities.”

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.